Myriad Genetics Files Q1 2025 10-Q Report
Ticker: MYGN · Form: 10-Q · Filed: May 7, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
MYGN Q1 2025 10-Q filed. Financials and operations updated.
AI Summary
Myriad Genetics Inc. filed its 10-Q report for the period ending March 31, 2025. The filing includes financial data and operational updates for the first quarter of 2025. Key financial figures and business segment information are detailed within the report.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Myriad Genetics, crucial for understanding the company's trajectory in the diagnostics sector.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the healthcare and diagnostics sector can be subject to regulatory and market risks.
Key Numbers
- 20250331 — Period End Date (The report covers financial data up to this date.)
- 20250507 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- MYRIAD GENETICS INC (company) — Filer of the 10-Q report
- 20250331 (date) — Period of report
- 20250507 (date) — Filing date
- SALT LAKE CITY (location) — Company headquarters city
- DE (location) — State of incorporation
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 7, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0000899923.
Where is Myriad Genetics Inc. headquartered?
Myriad Genetics Inc. is headquartered in Salt Lake City, UT.
What is the Standard Industrial Classification (SIC) code for Myriad Genetics Inc.?
The SIC code for Myriad Genetics Inc. is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding MYRIAD GENETICS INC (MYGN).